highly significantP <0.001
Importantly, a comparison between zaprinast-treated wt and PARG110 KO revealed a highly significant difference ( P <0.001; Figure 3r ), suggesting that lack of PARG110 expression and/or activity was neuroprotective.
Importantly, a comparison between zaprinast-treated wt and PARG110 KO revealed a highly significant difference ( P <0.001; Figure 3r ), suggesting that lack of PARG110 expression and/or activity was neuroprotective.